Tissue microarrays: applications in urological cancer research
- PMID: 16896596
- DOI: 10.1007/s00345-006-0103-1
Tissue microarrays: applications in urological cancer research
Abstract
Tissue microarrays (TMAs) are used to simultaneously study the expression of proteins in hundreds of tissue samples, offering the important advantage to screen large tissue banks for biomarker expression and to simultaneously examine serial sections obtained from the same tumor specimen by a time- and cost-effective analytical approach. This review article presents an overview of the importance and the impact of this technique in cancer research with increasing number of investigations using TMAs in its eighth anniversary. Its application, limitations, and selected previous study results regarding urologic malignancies are presented and discussed.
Similar articles
-
Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas.World J Urol. 2006 Nov;24(5):565-78. doi: 10.1007/s00345-006-0119-6. World J Urol. 2006. PMID: 17063322 Review. No abstract available.
-
[MicroRNAs as potential noninvasive markers in the diagnosis of urological malignancies].Urologiia. 2016 Apr;(2):96-102. Urologiia. 2016. PMID: 28247670 Russian.
-
[Structure of biobanks for urological research].Urologe A. 2015 Sep;54(9):1256-60. doi: 10.1007/s00120-014-3722-y. Urologe A. 2015. PMID: 25503899 Review. German.
-
Tissue microarrays: emerging standard for biomarker validation.Curr Opin Biotechnol. 2008 Feb;19(1):19-25. doi: 10.1016/j.copbio.2007.10.009. Epub 2007 Dec 3. Curr Opin Biotechnol. 2008. PMID: 18053705 Review.
-
The translational potential of microRNAs as biofluid markers of urological tumours.Nat Rev Urol. 2016 Dec;13(12):734-752. doi: 10.1038/nrurol.2016.193. Epub 2016 Nov 2. Nat Rev Urol. 2016. PMID: 27804986 Review.
Cited by
-
Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study.Diagn Pathol. 2008 Jul 15;3 Suppl 1(Suppl 1):S25. doi: 10.1186/1746-1596-3-S1-S25. Diagn Pathol. 2008. PMID: 18673514 Free PMC article.
-
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?World J Urol. 2013 Apr;31(2):345-50. doi: 10.1007/s00345-012-0844-y. Epub 2012 Mar 11. World J Urol. 2013. PMID: 22407328
-
Maspin protein expression correlates with tumor progression in non-muscle invasive bladder cancer.Oncol Lett. 2010 Jul;1(4):621-626. doi: 10.3892/ol_00000110. Epub 2010 Jul 1. Oncol Lett. 2010. PMID: 22966354 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources